Ketamine trial for major depression

A $2.1 million grant from the National Health and Medical Research Council announced today will see UNSW Professor Colleen Loo lead Australia’s largest clinical trial of ketamine as a new treatment for major depression.

Largest hospital redesign in NSW

The first works have begun on stage one of the largest hospital redevelopment in NSW, at Sydney’s Westmead Hospital, that will see the children’s and adult’s emergency departments combined.

69% say yes so why are we falling behind?

Roughly 1,600 people are currently on waiting lists to receive an organ transplant in Australia. But for many, the wait will be unsuccessful due to the low number of donors.

Cancer not chemo linked to cognitive decline

Almost half of all bowel cancer survivors experience memory loss and have difficulty with multitasking and concentration, according to research published in the Journal of Clinical Oncology.

Why we need a co-design approach to transitionary care

ICE - the new frontline

Ice, or methylamphetamine, has been around for years but in the past two to three years its use has surged as the drug gains a level of social acceptance that has caught Australia off-guard. Ice is everywhere.

Sitting is becoming the new smoking

There is a growing body of evidence that high levels of sedentary behaviour and sitting in particular are emerging risk factors for chronic disease including heart disease and type 2 diabetes. It may even cause premature death.

Can Medicare sustain the health of our ageing population?

Helena Britt, University of Sydney; Allan John Pollack, University of Sydney; Carmen Wong, University of Sydney; Christopher Harrison, University of Sydney; Clare Bayram, University of Sydney; Graeme Miller, University of Sydney; Janice Charles, University of Sydney; Joan Henderson, University of Sydney; Julie Gordon, University of Sydney, and Lisa Valenti, University of Sydney

Ignoring the evidence

Science fatigue keeps us clinging to bad health habits

Australia unprepared for bioterrorism attack

Australia’s first university-based bioterrorism course will launch this month, tapping into expertise from UNSW, the Australian Army, NSW Police and international bioterrorism and disaster authorities.

$43 million boost to tackle dementia

Seventy-six researchers will share in $43 million to support bold and innovative new ideas to not only tackle the impacts of dementia but to find ways of preventing and curing the debilitating disease.

Nanocapsules hijack then self-destruct

Australian researchers funded by the National Heart Foundation are a step closer to a safer and more effective way to treat heart attack and stroke via nanotechnology.

Immunotherapy - QIMR Berghofer’s T-cell therapies in clinical trials

Rewriting workplace diversity

Gender diversity might be a hot topic for HR executives, but the concern is not filtering through the organisation, new research from the Hay Group has found.

Regulating medicinal cannabis in Australia

From farm to pharmacy Nola Ries, University of Newcastle